Ginkgo Bioworks Corp. (DNA): Price to Sales

Corporate company logo of Ginkgo Bioworks Corp. (DNA)

The bioengineering market is currently transforming, shifting its focus toward AI solutions for agricultural and pharmaceutical behemoths. Ginkgo Bioworks Holdings (DNA) minimizes risks through cell programming services for various industries, although chip supply chain vulnerabilities create threats. The price-to-sales ratio on this chart demonstrates market expectations, where the latest value is recorded as 5.10.

DNA: ginkgobioworks.com Price-to-Revenue Ratio 07/04/2022 - 11/15/2026

Ginkgo Bioworks Corp. (DNA) - metric breakdowns and financial figures

- market price and analyst price targets:
- stock exchange capitalization data:
General company analysis:Ginkgo Bioworks Holdings, Inc., DNA
Core merchandise of Ginkgo Corp

The Ginkgo Bioworks Holdings (DNA) business model is based on long-term R&D contracts in synthetic biology, where demand is driven by the availability of venture capital rather than general economic conditions. The market capitalization-to-sales ratio quantifies market expectations for future expansion; therefore, the price-to-sales ratio dynamics allow for the diagnosis of asset overvaluation or hidden risks of prolonged capital stagnation.

Competitors of Ginkgo Bioworks Holdings